Search Results

There are 9313 results for: content related to: Treatment of Primary Chronic Glomerulonephritis with Rehmannia Glutinosa Acteosides in Combination with the Angiotensin Receptor Blocker Irbesartan: A Randomized Controlled Trial

  1. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects

    Biopharmaceutics & Drug Disposition

    Volume 36, Issue 4, May 2015, Pages: 216–231, Mohsen A. Hedaya and Sally A. Helmy

    Version of Record online : 4 FEB 2015, DOI: 10.1002/bdd.1935

  2. You have free access to this content
    A Review of the Clinical Experience with the Angiotensin II Receptor Antagonist Irbesartan

    Cardiovascular Drug Reviews

    Volume 18, Issue 2, June 2000, Pages: 103–126, Bernard Waeber

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2000.tb00038.x

  3. You have free access to this content
    A Review of the New Angiotensin II-Receptor Antagonist Irbesartan

    Cardiovascular Drug Reviews

    Volume 16, Issue 3, September 1998, Pages: 169–194, James R. Powell, Richard A. Reeves, Maria R. Marino, Catherine Cazaubon and Dino Nisato

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1998.tb00354.x

  4. You have free access to this content
    Amelioration of Systemic Fibrosis in Mice by Angiotensin II Receptor Blockade

    Arthritis & Rheumatism

    Volume 65, Issue 5, May 2013, Pages: 1367–1377, Wioleta Marut, Niloufar Kavian, Amélie Servettaz, Thong Hua-Huy, Carole Nicco, Christiane Chéreau, Bernard Weill, Anh Tuan Dinh-Xuan and Frédéric Batteux

    Version of Record online : 23 APR 2013, DOI: 10.1002/art.37873

  5. You have free access to this content
    The effects of age and gender on the pharmacokinetics of irbesartan

    British Journal of Clinical Pharmacology

    Volume 46, Issue 6, December 1998, Pages: 611–613, Nimish N. Vachharajani, Wen Chyi Shyu, Robert A. Smith and Douglas S. Greene

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00837.x

  6. Stability-indicating HPLC-DAD Method for Simultaneous Determination of Atorvastatin, Irbesartan, and Amlodipine in Bulk and Pharmaceutical Preparations

    Bulletin of the Korean Chemical Society

    Volume 36, Issue 9, September 2015, Pages: 2230–2237, Majdi M. Bkhaitan and Agha Zeeshan Mirza

    Version of Record online : 24 AUG 2015, DOI: 10.1002/bkcs.10433

  7. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone

    Journal of Clinical Pharmacy and Therapeutics

    Volume 23, Issue 6, December 1998, Pages: 433–440, J. Rosenstock, L. Rossi, C. S. Lin, D. MacNeil and M. Osbakken

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2710.1998.00184.x

  8. The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents

    The Journal of Clinical Pharmacology

    Volume 41, Issue 7, July 2001, Pages: 742–749, Dr. Abdullah Sakarcan, Dr. Frank Tenney, Dr. John T. Wilson, Dr. John J. Stewart, Dr. Kim G. Adcock, Dr. Thomas G. Wells, Dr. Nimish N. Vachharajani, Ms. Ophelia W. Hadjilambris, Dr. Peter Slugg, Dr. Neville F. Ford and Dr. Maria R. Marino

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700122010645

  9. Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 38, Issue 3, March 1998, Pages: 246–255, Dr. Maria R. Marino, Ms. Kathleen Langenbacher, Dr. Neville F. Ford and Dr. Howard D. Uderman

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04422.x

  10. Irbesartan-loaded electrospun nanofibers-based PVP K90 for the drug dissolution improvement: Fabrication, in vitro performance assessment, and in vivo evaluation

    Journal of Applied Polymer Science

    Volume 132, Issue 27, July 15, 2015, Ehsan Adeli

    Version of Record online : 31 MAR 2015, DOI: 10.1002/app.42212

  11. You have free access to this content
    An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy

    Value in Health

    Volume 11, Issue 3, May/June 2008, Pages: 354–364, Lieven Annemans, Nadia Demarteau, Shanlian Hu, Tae-Jin Lee, Zaher Morad, Thanom Supaporn, Wu-Chang Yang and Andrew J. Palmer

    Version of Record online : 21 SEP 2007, DOI: 10.1111/j.1524-4733.2007.00250.x

  12. You have free access to this content
    Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1

    British Journal of Pharmacology

    Volume 142, Issue 6, July 2004, Pages: 933–942, Shu-Meng Cheng, Shih-Ping Yang, Ling-Jun Ho, Tien-Ping Tsao, Deh-Ming Chang and Jenn-Haung Lai

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705785

  13. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 4, October 1999, Pages: 367–373, Gustav G. Belz, Raunhild Butzer, Susan Kober, Christian Mang and Ernst Mutschler

    Version of Record online : 14 OCT 1999, DOI: 10.1053/cp.1999.v66.a101162

  14. The Pharmacokinetics and Pharmacodynamics of Irbesartan in Heart Failure

    The Journal of Clinical Pharmacology

    Volume 41, Issue 9, September 2001, Pages: 935–942, Dr. John B. Kostis, Dr. Nimish N. Vachharajani, Ms. Ophelia W. Hadjilambris, Dr. Georgia D. Kollia, Dr. Maria Palmisano and Dr. Maria R. Marino

    Version of Record online : 19 MAR 2013, DOI: 10.1177/009127000104100902

  15. Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis

    International Journal of Clinical Practice

    Volume 61, Issue 10, October 2007, Pages: 1626–1633, A. J. Palmer, W. J. Valentine and J. A. Ray

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1742-1241.2007.01343.x

  16. Hydrophilic interaction chromatography-tandem mass spectrometric analysis of irbesartan in human plasma: Application to pharmacokinetic study of irbesartan

    Journal of Separation Science

    Volume 32, Issue 14, July 2009, Pages: 2353–2358, Hye Won Lee, Hye Young Ji, Eun-Seok Park, Kang Choon Lee and Hye Suk Lee

    Version of Record online : 17 JUN 2009, DOI: 10.1002/jssc.200900148

  17. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2−/− mice

    Liver International

    Volume 35, Issue 4, April 2015, Pages: 1451–1463, Kim R. Bridle, Amy L. Sobbe, C. Erika de Guzman, Nishreen Santrampurwala, Lesley A. Jaskowski, Andrew D. Clouston, Catherine M. Campbell, V. Nathan Subramaniam and Darrell HG Crawford

    Version of Record online : 10 MAR 2014, DOI: 10.1111/liv.12494

  18. You have free access to this content
    Irbesartan treatment up-regulates hepatic expression of PPARα and its target genes in obese Koletsky (fak/fak) rats: a link to amelioration of hypertriglyceridaemia

    British Journal of Pharmacology

    Volume 160, Issue 7, August 2010, Pages: 1796–1807, X Rong, Y Li, K Ebihara, M Zhao, T Kusakabe, T Tomita, M Murray and K Nakao

    Version of Record online : 3 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00835.x

  19. You have free access to this content
    Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 4, April 2012, Pages: 680–691, A. GEORGESCU, N. ALEXANDRU, E. ANDREI, I. TITORENCU, E. DRAGAN, C. TARZIU, S. GHIORGHE, E. BADILA, D. BARTOS and D. POPOV

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1538-7836.2012.04650.x

  20. You have free access to this content
    AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI

    British Journal of Pharmacology

    Volume 138, Issue 8, April 2003, Pages: 1485–1494, Quang T Nguyen, Federico Colombo, Robert Clement, Hugues Gosselin, Jean-Lucien Rouleau and Angelino Calderone

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705212